In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain | |
Tian, Xin-hua ; Wei, Feng ; Wang, Tian-xiao ; Wang, Peng ; Lin, Xiao-ning ; Wang, Jun ; Wang, Dong ; Ren, Lei ; Ren L(任磊) | |
刊名 | http://dx.doi.org/10.2147/IJN.S26541
![]() |
2012 | |
关键词 | CELL-PENETRATING PEPTIDES PEG-PLGA NANOPARTICLES QUANTUM DOTS LIPOSOMES MECHANISM EFFICACY VECTOR |
英文摘要 | National Natural Science Foundation of China [81172394, 30970733]; National Basic Research Program of China [2010CB732402]; Natural Science Foundation of Fujian Province of China [2006J0188]; Background: Nanobiotechnology can provide more efficient tools for diagnosis, targeted and personalized therapy, and increase the chances of brain tumor treatment being successful. Use of nanoparticles is a promising strategy for overcoming the blood-brain barrier and delivering drugs to the brain. Gelatin-siloxane (GS) nanoparticles modified with Tat peptide can enhance plasmid DNA transfection efficiency compared with a commercial reagent. Methods: SynB-PEG-GS nanoparticles are membrane-penetrable, and can cross the blood-brain barrier and deliver a drug to its target site in the brain. The efficiency of delivery was investigated in vivo and in vitro using brain capillary endothelial cells, a cocultured blood-brain barrier model, and a normal mouse model. Results: Our study demonstrated that both SynB-PEG-GS and PEG-GS nanoparticles had a spherical shape and an average diameter of 150-200 nm. It was shown by MTT assay that SynB-PEG-GS nanoparticles had good biocompatibility with brain capillary endothelial cells. Cellular uptake by SynB-PEG-GS nanoparticles was higher than that for PEG-GS nanoparticles for all incubation periods. The amount of SynB-PEG-GS nanoparticles crossing the cocultured blood-brain barrier model was significantly higher than that of PEG-GS nanoparticles at all time points measured (P < 0.05). In animal testing, SynB-PEG-GS nanoparticle levels in the brain were significantly higher than those of PEG-GS nanoparticles at all time points measured (P < 0.01). In contrast with localization in the brain, PEG-GS nanoparticle levels were significantly higher than those of SynB-PEG-GS nanoparticles (P < 0.01) in the liver. Conclusion: This study indicates that SynB-PEG-GS nanoparticles have favorable properties with regard to morphology, size distribution, and toxicity. Moreover, the SynB-PEG-GS nanoparticles exhibited more efficient brain capillary endothelial cell uptake and improved crossing of the blood-brain barrier. Further, biodistribution studies of rhodamine-loaded nanoparticles demonstrated that modification with the SynB peptide could not only improve the ability of PEG-GS nanoparticles to evade capture in the reticuloendothelial system but also enhance their efficiency in crossing the blood-brain barrier. |
语种 | 英语 |
内容类型 | 期刊论文 |
源URL | [http://dspace.xmu.edu.cn/handle/2288/59011] ![]() |
专题 | 材料学院-已发表论文 |
推荐引用方式 GB/T 7714 | Tian, Xin-hua,Wei, Feng,Wang, Tian-xiao,et al. In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain[J]. http://dx.doi.org/10.2147/IJN.S26541,2012. |
APA | Tian, Xin-hua.,Wei, Feng.,Wang, Tian-xiao.,Wang, Peng.,Lin, Xiao-ning.,...&任磊.(2012).In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain.http://dx.doi.org/10.2147/IJN.S26541. |
MLA | Tian, Xin-hua,et al."In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain".http://dx.doi.org/10.2147/IJN.S26541 (2012). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论